BranchLab Scores $26M Series A

BranchLab, a Boulder-based AI platform for pharmaceutical commercialization, raised $26 million in Series A funding.

The round was led by McKesson Ventures, with participation from FCA Venture Partners, Sanofi Ventures, and AIX Ventures.

Total funding for the company now stands at $35 million.

The capital will help BranchLab scale tools designed to support drugmakers in bringing therapies to market.